Griscelli syndrome (GS) is a rare autosomal recessive multisystem disorder of pigmentary dilution of skin, silver gray hair, variable immunodeficiency, neurological impairment and abnormal accumulation of melanosomes in melanocytes. The three different types of GS are caused by mutations in three different genes. Griscelli type 3 is due to mutations in the Mlph gene, characterized by hypomelanosis with no immunological and neurological manifestation. We report a 19 years old male with type 3 GS having only pigmentary dilution; silvery gray hair, eye brows, and eyelashes

1. Mancini AJ, Chan LS, Paller AS. Partial albinism with immunodeficiency: Griscelli syndrome: Report of a case and review of the literature. Journal of the American Academy of Dermatology. 1998; 38: 295-300.
2. Ménasché G, Pastural E, Feldmann J, Certain S, Ersoy F, et al. (2000) Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 25: 173-176.
3. Pastural E, Ersoy F, Yalman N, Wulffraat N, Grillo E, et al. (2000) Two genes are responsible for Griscelli syndrome at the same 15q21 locus. Genomics 63: 299-306.
4. Vieira-Karuta SC, Bertoldo Silva IC, Almeida NAP, De Noronha L, Santos MLSF, Liberalesso PBN. Griscelli syndrome and electroencephalography pattern Arquivos de Neuro-Psiquiatria 2008; 66(2B):420-2.
5. Klein C, Philippe N, Le Desit F, Fraitag S, Prost C, Durandy A, et al. Partial albinism with immunodeficiency (Griscelli syndrome). Journal of Paediatrics 1994; 125: 886-95.
6. Westbroek W, Klar A, Cullinane AR, Ziegler SG, Hurvitz H, et al. (2012) Cellular and clinical report of new Griscelli syndrome type III cases. Pigment Cell Melanoma Res 25: 47-56.
7. Ménasché G, Ho CH, Sanal O, Feldmann J, Tezcan I, et al. (2003) Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 112: 450-456.
8. Fukuda M, Kuroda TS, Mikoshiba K. Slac2‑a/melanophilin, the missing link between Rab27 and myosin Va: Implications of a tripartite protein complex for melanosome transport.J Biol Chem 2002; 277: 12432‑6.
9. Sanal O, Ersoy F, Tezcan I, Metin A, Yel L, Menasche G, et al. Griscelli disease: genotype- phenotype correlation in an array of clinical heterogeneity. Journal of Clinical Immunology 2002; 22: 237-44.
10. Schuster F, Stachel DK, Schmid I, Baumeister FA, Graubner UB, Weiss M, Haas RJ, Belohradsky BH. Griscelli syndrome: report of the first peripheral blood stems cell transplant and the role of mutations in the RAB27A gene as an indication for BMT. Bone Marrow Transplant. 2001; 28: 409–12.
11. Hurvitz H, Gillis R, Klaus S, Klar A, Gross‑Kieselstein F, Okon E. A kindred with Griscelli disease: Spectrum of neurological involvement. Eur J Pediatr1993;152:402‑5.
12. Schneider LC, Berman RS, Shea CR, Perez‑Atayde AR, Weinstein H, Geha RS. Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli syndrome). J ClinImmunol 1990;10:146‑53.
13. Ménasché G, Ho CH, Sanal O, Feldmann J, Tezcan I, Ersoy F, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F‑exon deletion (GS1). J Clin Invest 2003;112:450‑6.
14. Usha HN, Prabhu PD, Sridevi M, Baindur K, Balakrishnan CM. Chediak‑Higashi syndrome. Indian Pediatr 1994;31:1115‑9.

Shikha Verma

Senior Resident, Department of Pediatrics Dr RPGMC Kangra H.P India